These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2570434)

  • 1. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models.
    Heilig M; Söderpalm B; Engel JA; Widerlöv E
    Psychopharmacology (Berl); 1989; 98(4):524-9. PubMed ID: 2570434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 2-adrenoceptor antagonists potentiate the anticonflict and the rotarod impairing effects of benzodiazepines.
    Söderpalm B; Engel JA
    J Neural Transm; 1989; 76(3):191-204. PubMed ID: 2567344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amperozide in two animal models of anxiety.
    Engel JA; Egbe P; Liljequist S; Söderpalm B
    Pharmacol Toxicol; 1989 May; 64(5):429-33. PubMed ID: 2570418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y produces anxiety via Y2-type receptors.
    Nakajima M; Inui A; Asakawa A; Momose K; Ueno N; Teranishi A; Baba S; Kasuga M
    Peptides; 1998; 19(2):359-63. PubMed ID: 9493869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
    Trent NL; Menard JL
    Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
    Britton KT; Akwa Y; Spina MG; Koob GF
    Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice.
    Karlsson RM; Holmes A; Heilig M; Crawley JN
    Pharmacol Biochem Behav; 2005 Mar; 80(3):427-36. PubMed ID: 15740785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.
    Heilig M; McLeod S; Brot M; Heinrichs SC; Menzaghi F; Koob GF; Britton KT
    Neuropsychopharmacology; 1993 Jun; 8(4):357-63. PubMed ID: 8099792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
    Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y produces anxiolytic effects in spontaneously hypertensive rats.
    Pich EM; Agnati LF; Zini I; Marrama P; Carani C
    Peptides; 1993; 14(5):909-12. PubMed ID: 7904341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone blocks 'anxiolytic' effects of neuropeptide Y.
    Britton KT; Southerland S
    Peptides; 2001 Apr; 22(4):607-12. PubMed ID: 11311731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like action of centrally administered galanin.
    Bing O; Möller C; Engel JA; Söderpalm B; Heilig M
    Neurosci Lett; 1993 Dec; 164(1-2):17-20. PubMed ID: 7512244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.
    La Marca S; Dunn RW
    Life Sci; 1994; 54(10):PL179-84. PubMed ID: 7906377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
    Kokare DM; Dandekar MP; Chopde CT; Subhedar N
    Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally administered neuropeptide Y enhances the hypothermia induced by peripheral administration of adrenoceptor antagonists.
    Ruiz de Elvira MC; Coen CW
    Peptides; 1990; 11(5):963-7. PubMed ID: 1980942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SHR exhibits less "anxiety" but increased sensitivity to the anticonflict effect of clonidine compared to normotensive controls.
    Söderpalm B
    Pharmacol Toxicol; 1989 Nov; 65(5):381-6. PubMed ID: 2576131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptors.
    Heilig M; Wahlestedt C; Widerlöv E
    Eur J Pharmacol; 1988 Nov; 157(2-3):205-13. PubMed ID: 2852114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors.
    Söderpalm B; Engel JA
    Pharmacol Biochem Behav; 1988 Jun; 30(2):471-7. PubMed ID: 2845446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.